Interpretive reading of the antibiogram in gram positive COCCI;Lectura interpretada del antibiograma de cocos gram positivos

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 28, Issue 8, 2010, Pages 541-553

  Torres, Carmen ^a   Cercenado, Emilia ^b  

^a UNIVERSITY OF LA RIOJA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Antibiogram; Enterococcus; Mechanisms of resistance; Staphylococcus; Streptococcus

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAMASE; CEFOTAXIME; CEFTAROLINE; CEFTOBIPROLE; CEPHALOSPORIN; DNA TOPOISOMERASE; GLYCOPEPTIDE; LINCOSAMIDE; LINEZOLID; MACROLIDE; METHYLTRANSFERASE; MIKAMYCIN B; PENICILLIN G; PSEUDOMONIC ACID; QUINOLONE DERIVATIVE; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL STRAIN; ENTEROCOCCUS; ENZYME SYNTHESIS; GENE EXPRESSION; GENE MUTATION; GRAM POSITIVE COCCI; GYRA GENE; HUMAN; MECA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PARC GENE; PARE GENE; PHENOTYPE; POINT MUTATION; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 77957564531     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2010.02.003     Document Type: Article

References (34)

1. C. Jacqueline, J. Caillon, V. Le Mabecque, A.F. Migeville, Y. Ge, and D. Biek In vivo activity of a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, ceftaroline, against vancomycin-susceptible and -resistant Enterococcus faecalis strains in a rabbit endocarditis model: a comparative study with linezolid and vancomycin Antimicrob Agents Chemother 53 2009 5300 5302
2. M. Cheng, A. Antignac, C. Kim, and A. Tomasz Comparative study of the susceptibilities of major epidemic clones of methicillin-resistant Staphylococcus aureus to oxacillin and to the new broad-spectrum cephalosporin ceftobiprole Antimicrob Agents Chemother 52 2008 2709 2717
3. Clinical and Laboratory Standards Institute (CLSI). Performance Standards forAntimicrobial Susceptibility Testing. Nineteenth Informational Supplement. Vol. 29. Wayne, Pa. 2009. CLSI document M100-S19.
4. H.F. Chambers Methicillin-resistance in staphylococci: molecular and biochemical basis and clinical implications Clin Microbiol Rev 10 1997 781 791
5. S. Cores, P.S. Beisser, P.H. Terporten, C. Neef, R.H. Deurenberg, and E.E. Stobberingh Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus Clin Microbiol Infect 2009 in press
6. J.M. Swenson, W.B. Brasso, M.J. Ferraro, D.J. Hardy, C.C. Knapp, and L.K. McDougal Detection of Inducible Clindamycin Resistance in Staphylococci by Broth Microdilution Using Erythromycin-Clindamycin combination wells Journal of Clinical Microbiology 45 2007 3954 3957
7. C. Kehrenberg, and S. Schwarz Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates Antimicrob Agents Chemother 50 2006 1156 1163
8. Centers for Disease Control and Prevention Staphylococcus aureus resistant to vancomycin-United States, 2002 Morb Mortal Wkly Rep 51 2002 565 567
9. X. Malaviolle, C. Nonhoff, O. Denis, S. Rottiers, and M.J. Struelens Evaluation of disc diffusion methods and Vitek 2 automated system for testing susceptibility to mupirocin in Staphylococcus aureus J Antimicrob Chemother 62 2008 1018 1023
10. J.B. Locke, M. Hilgers, and K.J. Shaw Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700) Antimicrob Agents Chemother 53 2009 5265 5274
11. S. Besier, A. Ludwig, J. Zander, V. Brade, and T.A. Wichelhaus Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances Antimicrob Agents Chemother 52 2008 1570 1572
12. R. Del Campo, F. Cafini, M. Morosini, A. Fenoll, J. Liares, and L. Alou Combinations of PBPs and MurM protein variants in early and contemporary high-level penicillin-resistant Streptococcus pneumoniae isolates in Spain J Antimicrob Chemother 57 2006 983 986
13. J.J. Fenoll, L. Granizo, M.J. Aguilar, L. Gimnez, G. Aragoneses-Fenoll, and J. Hanquet Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007 J Clin Microbiol 47 2009 1012 1020
14. E. Bouza, C. Arenas, E. Cercenado, O. Cuevas, D. Vicioso, A. Fenoll and the Spanish Pneumococcal Infection Study Network (G03/103) Microbiologic workload and clinical significance of Streptococcus pneumoniae isolated during one week in Spain Microbial Drug Resistance 13 2007 52 61
15. L. Calatayud, C. Ardanuy, E. Cercenado, A. Fenoll, E. Bouza, and R. Pallares Serotypes, clones, and mechanisms of resistance of erythromycin- resistant Streptococcus pneumoniae isolates collected in Spain Antimicrob Agents Chemother 51 2007 3240 3246
16. Comit de l'Antibiogramme de la Societ Francaise de Microbiologie Recommandations 2007 Disponible en: http://www.sfm.asso.fr
17. E. Prez-Trallero, J.M. Marimn, L. Iglesias, and J. Larruskain Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates Emerg Infect Dis 9 2003 1159 1162
18. Sanz JC, Cercenado E, Marín M, Ramos B, Mndez N, Bouza E. High incidence of serotype 8 with resistance to erythromycin and levofloxacin causing invasive pneumococcal disease in HIV-infected patients in Madrid, Spain. 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco. USA. Septiembre 2009. Abstract L1-995.
19. B genotype of macrolide resistance in Spain, 1999 to 2005 Antimicrob Agents Chemother 51 2007 1228 1233
20. M. Montes, E. Tamayo, B. Orden, J. Larruskain, and E. Perez-Trallero Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain Antimicrob Agents Chemother 54 2010 93 97
21. K. Kimura, J. Wachino, H. Kurokawa, S. Suzuki, K. Yamane, and N. Shibata Practical disk diffusion test for detecting group B Streptococcus with reduced penicillin susceptibility J Clin Microbiol 47 2009 4154 4157
22. A. Portillo, M. Lantero, I. Olarte, F. Ruiz-Larrea, and C. Torres MLS resistance phenotypes in β-haemolytic group B, C and G Streptococcus isolates in La Rioja, Spain J Antimicrob Chemother 47 2001 115 116
23. N. Klibi, Y. Senz, M. Zarazaga, K. Ben Slama, F. Ruiz-Larrea, and A. Boudabous Polymorphism in pbp5 gene detected in clinical Enterococcus faecium strains with different ampicillin MICs from a Tunisian hospital J Chemother 20 2008 436 440
24. E. Cercenado, M.F. Vicente, M.D. Daz, C. Sánchez-Carrillo, and M. Sánchez-Rubiales Characterization of clinical isolates of beta-lactamase negative highly-ampicillin-resistant Enterococcus faecalis Antimicrob Agents Chemother 40 1996 2420 2422
25. J.F. Tomayko, K.K. Zscheck, K.V. Singh, and B.E. Murray Comparison of the beta-lactamase gene cluster in clonally distinct strains of Enterococcus faecalis Antimicrob Agents Chemother 40 1996 1170 1174
26. P.E. Coudron, S.M. Markowitz, and E.S. Wong Isolation of a beta-lactamase producing strain of Enterococcus faecium Antimicrob Agents Chemother 36 1992 1125 1126
27. J. Gavald, C. Torres, C. Tenorio, P. Lpez, M. Zarazaga, and J.A. Capdevilla Efficacy of ampicillin plus ceftriaxone in the treatment of experimental endocarditis due to Enterococcus faecalis highly-resistant to aminoglycosides Antimicrob Agents Chemother 43 1999 639 646
28. A. Portillo, F. Ruiz-Larrea, M. Zarazaga, A. Alonso, J.L. Martinez, and C. Torres Macrolide resistance genes in Enterococcus spp Antimicrob Agents Chemother 44 2000 967 971
29. R. Del Campo, C. Tenorio, C. Rubio, J. Castillo, C. Torres, and R. Gmez-Lus Aminoglycoside-modifying enzymes in high-level streptomycin and gentamicin resistant Enterococcus spp in Spain Intern J Antimicrob Agents 15 2000 221 226
30. R. Del Campo, J.C. Galn, C. Tenorio, P. Ruiz-GarbaJoséa, M. Zarazaga, and C. Torres New aac(6')-I genes in Enterococcus hirae and Enterococcus durans: effect on beta-lactam/aminoglycoside synergy J Antimicrob Chemother 55 2005 1053 1055
31. J.W. Chow Aminoglycoside resistance in enterococci Clin Infect Dis 31 2001 586 589
32. G. Werner, T.M. Coque, A.M. Hammerum, R. Hope, W. Hryniewicz, and A. Johnson Emergence and spread of vancomycin resistance among enterococci in Europe Euro Surveill 13 2008 pii=19046
33. The European Antimicrobial Resistance Surveillance System. EARSS results Informe 2008 Disponible en: http://www.rivm.nl/earss/result/
34. C. Torres, S. Escobar, A. Portillo, L. Torres, A. Rezusta, and F. Ruiz-Larrea Detection of clonally related vanB2-containing Enterococcus faecium strains in two Spanish hospitals J Med Microbiol 55 2006 1237 1243